New Orleans - The cosmetically engaged dermatologist has to pay attention to trends in botulinum use, according to Jean Carruthers, M.D. Dr. Carruthers and her husband, Alistair, introduced the neurotoxin for treatment of frown lines at the 1991 meeting of the American Society of Dermatologic Surgeons. The society embraced the born-again toxin and now, peering into 2004, predicts that it will prick through new frontiers. These include: enhancing upper lip fullness, treating enlarged masseter muscles, contouring the mandible area of the lower face, and eliminating multiple benign cystic lesions of the face.
Can at-home dermarollers give the same results as in-office microneedling or is that just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.
Though convenient, SPF-infused cosmetics rarely deliver their labeled protection level in real-world use, underscoring the continued need for a dedicated broad-spectrum sunscreen as the foundation of any routine.
The FDA approved therapies for melanoma, dermatomyositis, superficial basal cell carcinoma, and adolescent alopecia areata, while TYK2 inhibitors and rare disease filings advanced toward 2027 decisions.